Cholesterol-lowering agent myopathy (CLAM).
London
S F
SF
University of Colorado Health Sciences Center, Denver 80262.
Gross
K F
KF
Ringel
S P
SP
D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects; D006801:Humans; D008148:Lovastatin / Q000009:adverse effects; D009135:Muscular Diseases / Q000139:chemically induced*
D000924:Anticholesteremic Agents; D008148:Lovastatin; D015248:Gemfibrozil